Skip to Content

  • Search

View Additional Section Content

ECOG - S0438 - Randomized Phase II Trial of Bay 43-9006 ( Sorafenib; NSC-724772) with Either CCI-779 ( Temsirolimus; NSC-683864) or R115777 ( Tipifarnib; NSC-70218) in Metastatic Melanoma.

Clinical Trial Categories

  • Melanoma
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details